首页> 中文期刊> 《浙江临床医学》 >联合检测血胃蛋白酶原和糖类抗原724在胃癌诊断中的价值

联合检测血胃蛋白酶原和糖类抗原724在胃癌诊断中的价值

         

摘要

Objective To study the diagnostic value of serum pepsinogen(PG)and carbohydrate antigen 724(CA72-4)in gastric cancer. Methods 107 patients with gastric cancer,who were diagnosed by surgery and pathology during Jan.2012 to May 2015,were studied as gastric cancer group.100 people who came for a healthy check-up during the same time were chosen as control group. Radiation immunity analysis was used to study the expression of PG and CA72-4 in these two groups. Comparison analysis was used for the data. Results The expression of PGI and PG I/PG Ⅱin gastric cancer group was obviously lower than the control group(P<0.01),while the expression of CA72-4 was obviously higher than the control group(P<0.01). The positive rate of single test for PG or CA72-4 was much lower than joint test of PG and CA72-4. Conclusion Joint test of PG and CA72-4 has a diagnostic significance for gastric cance.%目的:探讨血清胃蛋白酶原(PG)、糖类抗原724(CA724)对胃癌诊断的价值。方法选择2012年1月至20l5年5月经临床手术及病理确诊的胃癌患者107例作为胃癌组。选择同期健康体检者100例作为对照组。采用放射免疫分析法检测两组受试者的血清PG、CA724,并进行两组对照分析。结果胃癌组血清PGI、PG I/PG Ⅱ水平显著低于对照组(P<0.01)、CA724水平显著高于对照组(P<0.01)。单一检测血清PG或CA724的阳性率低于联合检测的阳性率(P<0.05)。结论联合检测血清PG和CA724对胃癌的诊断有较高的价值。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号